Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Kansas City Area Summit Brings together CROs

admin-ajax copy

The Kansas City region is home to 200 life science companies employing more than 20,000 people on both sides of the state line. Those kind of numbers put the area on the map as being a significant industry leading hub for drug development, diagnostics, clinical research, and animal health. Amid this growing biotech industry hub are 90 contract research organization, or CROs as we call them, which provide research services outsourced on a contract basis. Read More >

Events  |  3 Comments  |  Email This Post
Tags: , , , ,

‘Life According to Sam’ About Hope and Medical Discovery

progeria_hbo_sam

HBO is currently airing a documentary about a 13 year old boy named Sam Berns, who is coping with a cruel and rare genetic disease, known as progeria, which ages and weakens its young victims. If you haven’t seen it, you might expect “Life According to Sam” to be a heartbreaking tale of a family’s struggles to cope with something that is out of their control. It is that, but it’s also so much more. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

The New Road to IPO in the Age of the JOBS Act

President Obama

Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend to fill the room. Furthermore, it should surprise no one that this year’s IPO discussions were upbeat. That is mostly attributable to the dramatically higher number of IPOs that have already occurred this year. Furthermore, according to Jeff Baumel, moderator of a panel covering this very topic, deals are closing faster this year – with a median time of just Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Successful Public-Private Partnerships

According to BayBio, biomedical companies that can harness the power of patient groups will get medicines, devices and diagnostics to market faster, cheaper and smarter, helping patients and rewarding investors. Gail Maderis, ‎President & CEO at BayBio, debuted their preliminary whitepaper entitled “Successful Public-Private Partnerships” today at the 2013 BIO Investor Forum. BayBio surveyed nearly 100 biotech and foundation CEOs, vice presidents of research, directors of patient advocacy and others across the United States. Following Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The New Demand for Biotech Industry Talent

scientists115x76

Biotechnology is a multi-disciplinary field involving the integration of knowledge and skills drawn from numerous disciplines, such as microbiology, biochemistry, genetics, molecular biology and chemistry. Traditionally, the field of biotechnology has required a workforce with a wide array of highly specialized skills and training. Interestingly though, a shift has begun to take place, favoring people with interdisciplinary academic training who can support more than one project team and work across multiple areas. On September 10, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: ,